Home » ulcerative colitis » Recent Articles:

Hemorrhoids Overview, Causes, Symptoms and Hemorrhoids Treatment

January 6, 2010 Hemorrhoids No Comments

Hemorrhoids have plagued humankind since time immemorial, yet many misunderstandings regarding hemorrhoidal complaints and disease still exist. Many laypersons and clinicians do not understand the anorectal area and the common diseases associated with it.

Frequency of Hemorrhoids

Up to one third of the 10 million people in the United States with hemorrhoids seek medical treatment, resulting in 1.5 million related prescriptions per year.
The number of hemorrhoidectomies performed in hospitals is declining. A peak of 117 hemorrhoidectomies per 100,000 people was reached in 1994; this rate declined to 37 hemorrhoidectomies per 100,000 people in 1997. Obviously, outpatient and office treatment… Continue reading

Abdominal Pain. Cause of abdominal pain

August 4, 2009 Abdominal Pain No Comments

[/caption]

Abdominal pain is pain that is felt in the abdomen. The abdomen is an anatomical area that is bounded by the lower margin of the ribs and diaphragm above, the pelvic bone (pubic ramus) below, and the flanks on each side. Although abdominal pain can arise from the tissues of the abdominal wall that surround the abdominal cavity (such as the skin and abdominal wall muscles), the term abdominal pain generally is used to describe pain originating from organs within the abdominal cavity. Organs of the abdomen include the stomach, small intestine, colon, liver, gallbladder, and pancreas… Continue reading

ADS:

Featured Content:

Growth Of Chronic Kidney Disease Highlights Need For Early Detection, Greater Knowledge Of Treatment Options

March 12, 2010

As the incidence of diabetes and hypertension continues to grow worldwide – and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems – the need for early patient education about kidney disease and treatment options, including home-based treatments, has become critical. More than 240 million people have diabetes and this figure is projected to rise to 380 million by 20251. In the United States alone, 17.9 million have been diagnosed with diabetes resulting in medical and indirect costs (e.g…

Go to Source… Continue reading

Medicine Shoppe And Medicap Pharmacy Statement On Franchisee Lawsuit

March 12, 2010

Terry Burnside, general manager and senior vice president responsible for Medicine Shoppe and Medicap Pharmacy operations, today issued the following statement in response to a lawsuit filed in U.S. District Court in the Southern District of Ohio by seven Medicine Shoppe and Medicap franchisees, purporting to represent a class: Medicine Shoppe is dedicated to serving the needs of retail pharmacies and to helping them succeed. This has been true since 1970 when we began, and it is a value we hold sacred today…

Go to Source… Continue reading

Boston Scientific Announces Schedule For ACC 2010

March 12, 2010

Boston Scientific Corporation (NYSE: BSX) announced the schedule of the Company’s major events and news announcements at the 59th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 13-16 in Atlanta. “We look forward to announcing 12-month results from the PERSEUS clinical program, which will provide important data on our third-generation drug-eluting stent, the TAXUS® Element™ Paclitaxel-Eluting Stent,” said Keith Dawkins, M.D., Senior Vice President and Chief Medical Officer for Boston Scientific…

Go to Source… Continue reading

Cancer Patients In Kent Gain Access To Advanced RapidArc(R) Radiotherapy Treatments From Varian

March 12, 2010

Cancer patients in Kent will gain access to advanced radiotherapy treatments with the decision by the Kent Oncology Centre to acquire two fully-equipped treatment machines from Varian Medical Systems (NYSE: VAR). The machines, due to be delivered to oncology departments in Maidstone and Canterbury in the spring, will mean these departments are among the first in the country to offer fast and efficient RapidArc® radiotherapy treatments…

Go to Source… Continue reading

Leading Varian-Equipped Proton Therapy Center Treats 100th Patient

March 12, 2010

Clinicians at the Rinecker Proton Therapy Center (RPTC) in Munich have treated their 100th patient using advanced proton therapy systems supplied by Varian Medical Systems (NYSE: VAR). The landmark treatment comes just three months after a second treatment gantry was commissioned at the center, which offers advanced pencil-beam proton scanning to cancer patients. These patients, requiring treatment for a wide range of cancers, have come from across Germany and 19 other countries, including Canada, Argentina, the UK and Switzerland…

Go to Source… Continue reading

AstraZeneca Comments On FDA Joint Advisory Committee Meeting On Post-Marketing Safety Studies For The Use Of LABAs In Asthma

March 12, 2010

On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) — including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees — discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate)…

Go to Source… Continue reading

The Results Are In: Users Of BodyMedia’s Wearable Body-Monitoring Technology Lose 3 Times More Weight

March 12, 2010

With obesity in America reaching alarming levels — across our adult and youth populations — results from a clinical trial unveiled by BodyMedia confirm that participants who used BodyMedia’s wearable body-monitoring technology either in conjunction with a group weight loss program or as part of their own self-directed program lost up to three times more weight than individuals who attempted to battle the bulge solo. BodyMedia Inc…

Go to Source… Continue reading

Newly-Published Study Reinforces Role Of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) As An Add-on Treatment That Significantly Reduces Epilepsy

March 12, 2010

UCB announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported the approval of Vimpat by the U.S. Food and Drug Administration (FDA) in 2008 for use as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and older. Previous studies have demonstrated that Vimpat has a novel mechanism of action…

Go to Source… Continue reading

Recent Comments:

  • symptoms of dementia: What's the difference between dementia and Alzheimers? what is the difference? I think my father may be suffering one of these? does anyone know the w...
  • rani: good blog thank 4 the info...
  • JourneyHome: McCarran-Ferguson was originally designed to empower both the federal government and the individual states so that they could act to prevent insurance...
  • Hydro Closet: Hi, I thought I would say you have a wonderful site and rich content. I bookmarked your site and have it in my reader now...looking forward to future ...
  • Allan Ono: Getting more usage from drugs already approved by the FDA for new indications seems like a very good way to expand treatment options without the hyper...